XIGAFUZE

Swiss trademark · 634953 · Word mark · Deleted

Register entry

Registration number
634953
Application number
57535/2012
Status
Deleted
Type
Word mark
Filed
Jun 20, 2012
Registered
Oct 8, 2012
Published
Oct 8, 2012
Deleted
Jan 14, 2023
Reason
Not renewed
Priority
08.02.2012 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für den Humangebrauch für die Behandlung oder Prävention von metabolischen Störungen, nämlich Diabetes, Fettleibigkeit, Hyperlipidämie, Insulinresistenz, metabolisches Syndrom.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 14, 2023

    Deleted, not renewed

    Published in Swissreg on 14.01.2023

  2. Oct 8, 2012

    Registered

    Published in Swissreg on 08.10.2012

Parties

Holder

Bristol-Myers Squibb Company

345 Park Avenue, New York, NY 10154, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.